Form 8-K - Current report:
SEC Accession No. 0001493152-24-040465
Filing Date
2024-10-08
Accepted
2024-10-08 17:07:14
Documents
29
Period of Report
2024-10-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43029
2 ex10-1.htm EX-10.1 13835
3 ex10-1_001.jpg GRAPHIC 510179
4 ex10-1_002.jpg GRAPHIC 575675
5 ex10-1_003.jpg GRAPHIC 633797
6 ex10-1_004.jpg GRAPHIC 519857
7 ex10-1_005.jpg GRAPHIC 597252
8 ex10-1_006.jpg GRAPHIC 474561
9 ex10-1_007.jpg GRAPHIC 526206
10 ex10-1_008.jpg GRAPHIC 612185
11 ex10-1_009.jpg GRAPHIC 600128
12 ex10-1_010.jpg GRAPHIC 630381
13 ex10-1_011.jpg GRAPHIC 623505
14 ex10-1_012.jpg GRAPHIC 609337
15 ex10-1_013.jpg GRAPHIC 617656
16 ex10-1_014.jpg GRAPHIC 188924
  Complete submission text file 0001493152-24-040465.txt   10864393

Data Files

Seq Description Document Type Size
17 XBRL SCHEMA FILE ibo-20241003.xsd EX-101.SCH 3033
18 XBRL LABEL FILE ibo-20241003_lab.xml EX-101.LAB 34240
19 XBRL PRESENTATION FILE ibo-20241003_pre.xml EX-101.PRE 24178
32 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3534
Mailing Address 1400 BROADFIELD BLVD. SUITE 130 HOUSTON TX 77084
Business Address 1400 BROADFIELD BLVD. SUITE 130 HOUSTON TX 77084 585 232 1500
IMPACT BIOMEDICAL INC. (Filer) CIK: 0001834105 (see all company filings)

EIN.: 853926944 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42212 | Film No.: 241360899
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)